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To study the functional reactivity of the cutaneous microcir-
culation in progressive systemic sclerosis (PSS), hyperemic 
responses after arterial occlusion (3 min) and during local 
heating (42 °C) were investigated with simultaneous mea-
surements of red blood cell flux and cutaneous oxygen ten-
sion (Pcu02) of the skin in female patients (n = 19) with PSS 
and in healthy female controls (n = 15). Additionally, serum 
levels of 6-keto-prostaglandin la (PGF1a), a stable metabo-
lite of prostacyclin, were compared to the microcirculatory 
data, and both were used to evaluate further a standardized 
therapy with 10-d intravenous calcitonin (100 IU/d) infu-
sion in six PSS patients. 
In PSS, the initial mean Pcu02 value was significantly re-
duced and was inversely proportional to flux and to PGF1a 
levels, whereas the flux and Pcu02 responses to the above 
hyperemic stimuli showed significant reductions, revealing a 
pattern of "hyperemic hypoxia" probably due to exhausted 
T he cause of progressive systemic sclerosis (PSS), char-acterized by fibrosclerosis of cutaneous and visceral connective tissues, diffuse vascular damage, and im-munologic abnormalities, is still unknown. Typical microvasculatory abnorma lities are focal telangiecta-
sis [1], Raynaud's phenomenon, and stenosis of small arteries with 
entailing tissue damage. Thus, primary damage at the vascular and 
probably endothelial level is in one view involved in the pathogene-
sis of PSS [2,3]' whereas others [4 -6] hypothesize an alteration in 
collagen metabolism, possibly due to the abnormal release of cyto-
kines from mononuclear and/or endothelial cells [7] . 
Recent microcircu latory studies of oxygen tension [8,9] and/or 
skin blood flow [10 - 12] demonstrated significant differences be-
tween PSS and healthy subjects. In addition , there are contrasting 
reports of reduced prostacyclin (PGI2) levels in the skin [13] and of 
elevated PGI2 levels in the peripheral venous blood of PSS patients 
[14], but without simultaneous data on microcirculation. A major 
compound in the prostaglandin pathway that can be determined in 
blood plasma by its stable metabolite 6-keto-PGF ,a [15]. PGIz is a 
potent vasodi lator acting on the muscle cells of precapillary vessels 
[16]. It modulates platelet actions and presumab ly, with several 
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functional reserves of cutaneous perfusion. During calcitonin 
infusion significant rises in Pcu02 and temporarily in PGF1a 
and flux were found. After 10 d of therapy, increased PcuOz 
was associated significantly with decreased flux , indicating a 
.shifting of blood from deeper regulatory vessels to the sub-
epidermal capillaries. 
Both clinical improvement and the results of microcircu-
latory measurements demonstrate a beneficial effect of calci-
tonin on the cutaneous microcirculation in PSS patients, pos-
sibly due in part to a short-term increase in release of 
endogenous prostacyclin from the vascular endothelium 
during the infusion. The disturbed reactivity of the dermal 
vessels in PSS is important for the evaluation of therapeutic 
concepts and stresses, together with the elevated PGF1a 
plasma levels, vascular factors in the pathogenesis of PSS. 
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other prostagland in metabolites , also modulates inflammatory and 
immunologic reactions in early-phase PSS [17]. Accordingly, the 
action of PGI2 could represent a link between the two opposing 
views of the pathophysiology of PSS. 
A remarkable improvement of the deranged cutaneous microcir-
culation measured by thermography [16,18] was reported after 
short-term infusion of PGI2 • Furthermore, r.ecent laboratory data 
[19] with respect to pharmacologic effects of calcitonin agreed well 
with our experience of a favorable clinical course in PSS patients 
treated with short-term calcitonin infusions. This encouraged us to 
design a prospective study, firstly to correlate functional parameters 
of microcirculation devised by our group and simultaneous PGF1Q 
plasma levels in patients with PSS and healthy controls. Secondly, 
we wanted to determine the effect of calcitonin on microcirculatory 
parameters of the skin before, during, and after treatment. Plasma 
levels of PGF
'Q were investigated simultaneously to test a possible 
effect of calcitonin on the metabolism of endogenous prostacyclin, 
as has been suggested by several authors [20,21]. 
MATERIALS AND METHODS 
Patients, Control Group, and Therapeutic Regimen Cutaneous mi-
croci rculation was studied in 19 women suffering from PSS (type I and II 
[22], agcs 45 to 65 years, mean 58 years) and in 15 hcalthy non-smoking 
age-matched women serving as a control group. Intake of any vasoactive 
drugs was discontinued 4 weeks prior to the study. 
All measurcments were carried out at a controlled room temperature 
(2YC) in the morning before breakfast, using the left hand positioned at 
heart level. Measurements began after 30-min equilibration of paticnts and 
control subjects resting in supine position (day 0). 
On the next day (day 1) each patient was treated with 100 IU salmon 
calcitonin (Calcitonin L, Rorer Co., Germany) dissolved in 250 ml isotonic 
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Fig ure 1. Original recordings of laser-Doppler flu x (Flux) and cutaneous 
p02 (Pcu02) in a hea lthy subject during the entire procedure. IV, initial 
va lues; ZF, zero flux; HRTp'" post-occlusive hyperemic recovery time; 
MVpo, maximum post-occlusIve va lues; fVbl" in itial va lues before heating; 
EV h' end va lues after heating. 
saline so lution, by in travenous in fusion of 2.5 h duration, once a day fo r 10 
conseclltive days. Plasma leve ls of PGF
"
" red blood ce ll flux (flux), and 
cutaneous oxygen tension (Pcu02) were de termined at days 0 and 11 in all 19 
patients. Additionally, flux and Pcu02 were measured continuously and 
PG F'a seru m leve ls were de termined at 45-min intervals during the ca lci-
to nin infusion at days 1 and lO in six pa ti en ts. Furthermore, in thi s subgroup 
the ini t ial measurements were repeated during the subsequent control infu-
sion of isotonic sa line so lution (250 ml) over 2.5 h also on day O. 
Cutaneous Oxygen Tension C utaneous oxygen tension was measured 
polarographica lly using a transcutaneous oxygen probe containing three 
platinum wi re electrodes at a mutual d istance of 2 mm [23) (Oxymo ni to r, 
H ellige , Germany). The measured p02 is the mean p02 in a skin area of 
approximately 4 m m diameter. The ptobe itse lf with the built-in heating 
system had a d iameter of 2.0 cm . A probe temperature of 37"C w as used. 
The P0 2 va lues at 37'C, termed cutaneous p02 (Pcu02)' give information 
about the epidermis and the papillary body [8] and depend more on local skin 
propert ies including capillary fl ow than on the arteri al oxygen tension. 
Because inter- and intraindividual differences in epidermal t hickness and 
capillary de nsity may reduce the comparabili ty of individual data, the sk in 
positio n of the probe and probe holder w as marked exactl y to ensure that 
measurements were comparable. Additional stimulatory tests arc necessary 
to overcome the variability of p02 measurements at 37 'C [24,25]. 
Red Blood Cell Flux Red blood cell flux was measured simul taneously 
beside the p02 electrode w ith a lase r-Doppler fluxmeter [26,27] (Periflux 
Pfl d , Perimed , Sweden) having a tube-shaped probe of5 mm outer diameter 
and a sam pling w indow of 1 mm. Due to the deep skin penetration of the 
lase r light, capillaries, dermal arterio les, and venules arc w ithin the measur-
ing volume (1 - 2 mm in diameter) . D epending on the measuring site, part o r 
all of these vessels can contribu te to the flux signal. Pul se synchronous flux 
oscillations can therefore be observed using a time constant of 0.2 seconds 
(Fig 1) and a frequency shift cut-off at 12 kHz, corresponding to a mean 
max imum detectable blood ce ll velocity of approximately 4 mm/second. 
H owever, it is not possible to determine which part of the laser-D oppler flux 
(LDF) signal arises from w hich precise anatomic structure within the mea-
suring volume. M easurements at multiple sites , w hich would reduce this 
probl em [28], could not be done in our study. To compensa te fo r this we 
chose a single site with relatively hi gh flux values in regard to the stimulus-
response experiments (Table f). 
Measurement ofPGF'a Plas ma levels ofP GF 'a were determined duri ng 
infusio n o f calcitonin and sa line by radio immunoassay as desc ribed else-
where [1 9J after stable values for flu x and Pcu02 had been reached, using 
1 O-m l blood samples taken fro m the right cubital vein via a catheter placed at 
least 30 min before the fi rst blood sample was obtained [29]. 
Placement of the Probes T o find the best temperatures and sites fo r 
measurement, we determined flux and skin-surface temperature [same site, 
contact thermometer (TTW H 11 , Digimed, Germany)J on unheated skin at 
the dorsa l as pect of the wrist, mid hand and metacarpal bone of digit III, and 
on the fin gertip of di git III. To compare the differe nt sites, we studied mean 
fl ux va lues fo r 5 min after stable signals were reached fo llowing the applica-
tion of the unhea ted laser probe to the marked sites. Because the highest flu x 
values (in PSS), except for th e fin gertip, were found at the do rsa l midha·nd 
(Table f) prox imal to dig it III , we chose this site, w hich was always sclero tic 
in our pa tients. 
T he different in nerva tion contro l and the va riety of vessels present at the 
fin gertip make it an unsati sfactory site because both probes could no t be 
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Table I. Flux and Skin-Surface T empera ture at D ifferent 
Sites on th e Unheated Skin (Hand) In Patients with 
PSS (n = 19) and Controls (n = 15)' 
Site 
Wrist 
D orsa l hand 
D igitus 3 
Fingertip 
Contro ls 
Flux Measurements 
Flux[r UJ 
9.70 ± 2.48 
14.73 ± 5.45 
19.73 ± 9.22 
124.40 ± 62.90 
Temperature Measurements 
Site 
Wrist 
Dorsal hand 
D igitus 3 
Fingertip 
" Mea n ± sta ndard deviation. 
'p < O.D1 . 
' p < 0.05. 
J P < 0.001 . 
, Not significant, p < 0.05. 
T ['C] 
29 .21 ± 1.96 
30 .02 ± 1.86 
30 .80 ± 2.36 
32.07 ± 2.24 
PSS 
Flux[r U ) 
19.95 ± 9.58' 
29.85 ± 17.46' 
26.25 ± 18.63' 
77 .45 ± 47.2Q4 
T[ ' C] 
29.87 ± 1.64' 
29.98 ± 1.72' 
28.76 ± 2.90' 
26.98 ± H Od 
placed on one fin ger. T ranscutaneous measurement of p02 requires a skin/ 
probe temperatu re o f at leas t 37'C. With the oxygen and flux probe closely 
adjacent to each o th er, we chose to measure the red blood ce ll flux at a similar 
temperature (36'C due to the Periflux equipment) , which , as compared to 
unheated skin, produces a moderate d ilatation of the microvasculature. Be-
cause vessels in general were only partially d ilated, stimulatory tests yielded 
satisfactory respo nses (Fig 1) and can considerably reduce the interindividual 
variability [25]. 
Functional reactivity of cutaneous m icrocirculation was tested by stimu-
lus-response experiments. After stable initial values w ere obtained, abrupt 
arterial occlusion was prod uced by immediate auto matic inflation of a stan-
dard-sized blood pressure cuff to 40 mm H g above systo lic pressure. Zero-
perfusion was maintained for 3 min , and the cuff was then deflated . After 
10 min recovery time, both probes were hea ted to 42'C (using the built-in 
electrica l heating system with identica l time patte rn) . All data were continu-
ously recorded during occlusion, hea ti ng , and up to 25 min thereafter 
(Fig 1). 
Statistics Statist ica l analysis was done by Student t test after correcting all 
flux va lues fo r the individual "0 flux" during occl usion to improve the 
interindividual comparability of the data [30). The pre- and post-therapeutic 
data of the patients we re compared. The data during ca lcitonin infusion were 
analyzed by Wilcoxon's ra nk sum test comparing values of day 1 and 10 to 
the data during saline infusion of the sa me individuals. p values of 0.05 were 
considered signifi cant . 
The data for flux and Pcu0 2 were eva luated fo r each test separately with 
regard to their levels, time courses, and relatio n to each other. In this way, we 
could specify the fo llowing parameters as relevant to the microcirculatory 
response to defi ned stimuli . 
Occlusion Parameters Studied for PcuO, and Flux IV, initial values 
for Pcu02 (at 37 'C) and flux (at 36'C); ZV, 0 flu x; MV po, maximum post-
occlUSive va lues; HRV pO' pos t-occlusive hyperemic response va lues (MV -
IV); HRT PO' post-occlusive hyperemic recovery time up to MV Po; and OE, 
occlusion effect (HRVpo*10/ HRTpo)' 
Heating P ar a meters Studied for PcuO, a nd Flux IV"h' initial values 
before heat ing; EVI" end va lues after 25 min fo r flu x and Pcu0 2 at 42'C; and 
RW, regulation wid th (EV,, - IVbh) . 
RESULTS 
Table I shows th e comparison of flu x and temperature values 011 
four different unh eated skin sites in PSS patients and healthy con-
trols. W e found a significant twofo ld (p < 0.05) elevation of mean 
flu x at the wrist and the dorsal midhand and a 100% (p < 0.001) 
lower flux at the fin gertip in PSS patients compared to controls. 
Except for the temperature at the fin gertip, which was significant! 
(p < 0.001) lower in patients than in controls, 110 significant differ-
ences in skin-surface temperatures could be found. 
D etails concernin g stati c as well as dynamic parameters of cuta-
neous microcirculation are presented in T able II. Pronounced dif-
ferences in the mean ini tial values fo r flu x and PcuOz between the 
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Table II. Static and Functional Parameters (Occlusion and Heating) of Cutaneous Microcirculation in Patients with PSS' 
Occlusion parameters 
Initial Values 
H yperemic recovery time 
Maximum post-occl usive va lue 
Post-occlusive hyperemic response va lue 
Occl usion effect 
Heating Parameters 
Initial va l ues before heating 
Endvalues after heating 
Regulation width 
• Mean ± standa_rd deviario n . 
• p < 0.05. 
' p < 0.001. 
J P < 0.01. 
, Not significant, p < 0.05. 
Pc"Ozll11l11 Hg] 
Flux[r Uj 
Pc,,02[Sj 
Flux[s] 
pc,,02[ml11 Hgj 
Flux[r Uj 
pc,,02[mm HgJ 
Flux[r Uj 
p",Ozlmm Hg/sj 
Flux[r U/sJ 
Pc,,02[ ml11 Hg] 
Flux[r Uj 
pc..o2[mm HgJ 
Flux[r UJ 
p",02[mm HgJ 
Flux[r UJ 
controls and th e patients are shown in Fig 2. The dynamic parame-
ters (Table II) revealed highly significant lower mea n values for the 
occlusion effect (p < 0.001) and regulation width (p < 0.01) in th e 
patients. All the other dynamic parameters listed in Table II , espe-
cia lly th e post-occlusive hyperemic response value and the post-oc-
cl usive hyperemic recovery time, which both reflect the microcir-
culatory function al performance, were also significantly reduced in 
the patients. These data indicate a diminished capability of the cuta-
neouS microcircu lation to respond adequately to functional de-
mands in the altered tissue. 
Concerning th e effect of calcitonin infusion, we found before 
therapy a marked rise of flux (167%) combined with a decreased 
Pcu02 (65%) in the pati ents in co mparison with the control group. 
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Figure 2. Baseline values of PGF,o' flux , and Pc,,02 (mean ± SO) in pa-
tients with PSS (n = 19) and in healthy controls (n = 15). Same parameters 
(mean) during infusion of calcitonin (days 1 and 10) and saline in patients 
with PSS (n = 6). 
Controls 
(n = 15) 
4.04 ± 2.05 
15.83 ± 9.30 
101.33 ± 21.30 
16.93 ± 6.49 
12.83 ± 3.05 
51.40 ± 14.47 
8.85±2.14 
35.57 ± 10.26 
0.88 ± 0.27 
24.00 ± 10.24 
4.65 ± 3.42 
15.52 ± 11.35 
45.50 ± 12.88 
90.20 ± 31.60 
38.05 ± 11.75 
63.05 ± 24.65 
PSS 
(n = 19) 
2.62 ± 1.336 
42.26 ± 20.96' 
139.84 ± 22.04' 
39.10 ± 18.25' 
7.66 ± 2.6 1' 
66.21 ± 21.186 
4.90 ± 2.61 ' 
25.72 ± 7.85" 
0.35 ± 0.18' 
7.28 ± 3.02' 
6.35 ± 3.42' 
47.95 ± 23.99' 
29.95 ± 11.94" 
89.11 ± 36.75' 
25.69 ± 10.29' 
42.25 ± 15.25" 
After therapy, the mean Pcu02 increased significa ntly up to the 
levels of healthy controls, and mean flux significantl y decreased 
(30%, see Fig 2), but with no significant difference observed in th e 
pre- and post-treatment PGF
'a leve ls. However, during calcitonin 
infusion a temporary (at 45 min) significant increase ofPGF
'a level 
on days 1 and 10 coincided with a marked rise of Pcu02' whereas the 
mean flux increased significantly onl y at day 1. During saline infu-
sion all parameters remained constant. 
DISCUSSION 
The methods used (LDF and Pcu02) have physiologic limits due to 
the inter- and intraindividual heterogeneity of microcirculation 
[27 ,31 ,32] but provide the advantage of non-invasiveness and con-
tinuous measurements . The restrictions have to be kept in Inind 
even when minimizing external and internal influences on the mi-
crocirculation. Therefore, individual microcirculatory data should 
not simply be compared with eac h other, even those of a group of 
individuals may display great standard deviations. However, most 
investigators in this field regard th e comparison of such groups as 
va lid if the data from different groups show statistically significant 
differences. The close positioning of the flux and oxygen probes 
provides m easurements of adjacent but not identical spots of micro-
vasculature, as combined electrodes would do [33] . 
Although a number of studies on microcirculation in PSS usin g 
different single methods have been done [8 -11], results of the si-
multaneous application of several non-invas ive methods have not 
been published. A very recent study [12] on PSS used LDF and 
oxygen tension measurement consecutively, yet no stimulatory tests 
with time responses were carried out. 
Hyperemia due to arteria l occlusion ca n well be reproduced 
showing a typical pattern of hyperemic respo nse [33 ,34]. However, 
th e physiologic mechanisms involved in reactive hyperemia are not 
fully e lucidated, despite the frequent use of dynamic tests 
[11 ,33,35,36]. Different views on th e cause of post-occlusive hy-
peremia focus on accumu lation of vasodilating m etabolites in th e 
tissue or intravasal changes of pressure and so-called compliance, 
i.e., e lasticity and distensibility, of the vessels [37]. 
The microcirculatory response to loca l heating always revea led a 
biphasic pattern with a first and second maximum (Fi g 1) indicating 
a sensitive vascu lar mechanism that controls the interaction of ther-
moregulation , local perfusion , oxygen demand, and supply of tissue 
[38]. After the first peak, the declines of flux and Pcu02 reflect the 
vascu lar adjustment toward the new level of temperature and the 
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changed pe rfusion. Further penetration of warmth into the skin 
mobilizes ad ditional blood reserves for perfusIO n from the deeper 
vessels, leading to a slower but steady increase of Pcu0 2 and flu x. 
T herefore, their final values at 42 °C (EVh) provide, with respect 
to the initial values (IVbh) , the so-called regul ation w idth 
(RW = EVh - IVbh) as a partial measure fo r w hat has been termed 
cutaneous vascular reserve [33]. 
T hc di ffe rences found in flu x on unheated skin between the PSS 
and control groups (Table I) do not correlate w ith the measured skin 
surface temperatures except for the fin gertip. The latter can hardly 
be compared to the dorsal mid hand owing to different innervation 
and microvasculature [10,11] . The inverse relationship between 
pcu021evel and flux fo r the initial values (Table II) is partly consi~ t­
ent w ith a known decreased capillary denSity 111 sclerotiC sk111. 
H owever, this may not be the sole reason because th e relationship 
changes after therapy (Fig 2) , and capillary density is unlikely to 
increase significantly just as a result of a 10 d infusion. Therefore, 
th e lowered pcu021evels, apart from reduced capillary network, may 
also be due to impaired oxygen diffusion from the capillaries to the 
skin surface as well as to perivascular fibrosclerosis and partial thick-
enin g of the dermis [39]. The simultaneously observed elevation in 
flu x seems to refl ect a compensatory increased perfusion of the 
pre-capill ary va~cul ature.' th ereby maintaining a minimal circula-
tion in the nutntive-caplllary area [40]. Furthermore, the elevated 
pl asma levels o.f PGF1a (Fig 2) could indicate a vascul ar mechanism 
reactive to penpheral hypOXia. 
O ur results confirm those obtained by Belch el al [1 4] and seem to 
contradict reduced PGF 1a levels found by Hensby et al [1 3] in PSS 
skin w ith a suction-blisterin g technique. The disparity, however, 
may be due to disturbances ofl ocal prostaglandin metabolism in the 
affected skin th at are possibly counteracted through a compensatory 
increase of PGI2 production by endothelial cells of still uninvolved 
larger vessels. Of course , this hypothesis requires comparative in-
vestigations of the PGI2 levels, both in skin and ve nous blood, also 
wi th regard to the suction procedure . Furthermore, it should be 
studied wheth er the elevation of PGI2 plasma levels refl ects a com-
pensatory reaction to periph eral hypoxia or inflammatory metabolic 
changes in the tissue. 
Both the post-occlusive hyperemic response value (HRVpo) and 
the speed of post-occlUSive recovery (HRTpo) yield appropriate 
measures for the limited reactivity of the dermal vasculature to 
hypox ia and ischemia in PSS [11 ,35]. Additional dy namic parame-
ters such as occlusion effect also indicate a significa ntly reduced 
ability for post-occlusive compensation through the peripheral ves-
sels in the patients unlike the healthy controls. 
Former studies us ing the 133Xenon washout method on subcuta-
neous tissue in PSS suggested a lowered skin compliance of the 
fin gertips [35] and found unchanged distensibility of the vascular 
bed on the dorsum of the hand [41] . Similarly, our findin gs of 
strongly reduced vascul ar reactivi ty do not suggest a diminished 
distensibility of the cutaneous vessel walls w ithin th e measurin g 
volume of LDF. Instead, th e decreased reactivity of the dermal 
vessel s in our studies refl ects mainly exhaustion of their functional 
perfusion reserves. This view is based on the observation that th e 
post-occlusive hyperemic flu x responses (HRV po) are limited by the 
elevated initial value (IV) and not by a restriction of the maximum 
post-occlusive values (MV po) (Table II). In contrast, for Pcu02, th e 
reduction of HR V po mainly depends on a restricted MV 0 even 
despite a reduced IV. These data indicate that increased blobd flow 
in the deeper vesse ls insufficiently compensates for reduced capil-
lary perfusion and its consequently lowered epidermal oxygen sup-
ply. A similar type of "hyperemic hypox ia" has been found in the 
surrounding tissue of leg ulcers by chronic venous insufficiency 
[42]. 
In contrast to the control group, which showed the same Pcu02 
values before and after occlusion (IV and IVbh) , there was a marked 
increase of IVbh compared to IV for Pcu0 2 in PSS patients. This 
could indicate a longer las tin g reactive hyperemia in the capillaries 
to cover th e post-ischemic oxygen demand. Additionally , a possible 
protective reduction of local epidermal oxygen consumption could 
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lead to higher Pcu02 values on the skin surface . H owever, for valid 
comparison with the healthy controls·, the same experimental set-
up, i. e., 10 min recovery time, that proved sufficient in the controls 
had to be used in th e patients group as well. 
T he prolongation of HRT 0 detected in our PSS patients con-
firm s similar results of Goodfield et al [11] and points to an altered 
compliance of th e dermal vessels due to their disturbed reactivity 
and/or to the fib rosclerotic perivascular tissue. Moreover, the 
marked reduction of the dynamic parameter regul ation width for 
Pcu0 2 supports th e th eory of an insuffic ient epidermal oxygen sup-
ply by severely res tricted oxygen diffusion and capillary perfusion 
despite mobilization of blood from deeper dermal vessels. The mark-
ably restricted regulation w idth also fo r flu x cl earl y demonstrates.a 
reduced cutaneous vascular reserve [33], allowing only small addi-
tional flu x increases ow ing to the elevated initial value. 
The significant therapeutic rise of Pcu02 up to the level of healthy 
contro ls combined w ith a significant decrease in flu x after calcl-
torun therapy may be caused by a benefi cial shiftin g of blood from 
deeper regul atory vessels to the subepidermal nutritional capillaries. 
Our data, togeth er with an improvement in th e patients' general 
state, may be partly due to a short-term release of endogeneous PGI2 
from the endothelial cells during the in fusion. However, the reason 
for the prolonged favorable th erapeutic effects of the therapy on 
Pcu02 and flu x despite a change in the post-therapeutic PGF1a levels 
is still unknown. Further fo llow-up studies, especially of the reac-
tivi ty of the dermal vesse ls after calci tonin infusion, may elucidate 
this matter. 
In conclusion, the present study yields ample evidence for a se-
verely disturbed reactivity of the dermal vessels in PSS patients and 
demonstrates that non-invasive tes tin g of microcirculatory func-
tions provides important and reliable additional parameters for the 
evaluation of therapeutic agents such as calcitonin. 
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